Shattuck Labs Inc (STTK NASDAQ) stock market data APIs
$1.9997
-0.14(-7%)
as of November 17, 2025
Try our APIs with
free plan!
Shattuck Labs Inc Financial Data Overview
Price chart is built with
Anychart
Shattuck Labs, Inc., a biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases. The company's lead product candidate includes SL-325, a DR3 blocking monoclonal antibody, which activates immune responses through binding a single receptor, DR3; and SL-425. It also develops multiple preclinical DR3-based bispecific antibodies for the treatment of inflammatory bowel disease; and a series of bispecific antibodies targeting DR3 and other clinically validated targets. In addition, the company is involved in the advancement of its lead TRIM7 inhibitors through preclinical development as future internal pipeline candidates in oncology. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.
Prev. Close
1.9997
Open
1.8636
High
2.018
Low
1.8688
52 wk Range
0.692-2.705
Market Cap
125 M
Shares Outstanding
63 280 K
Revenue
1 000 K
EPS
-0.14
Beta
1.718
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shattuck Labs Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shattuck Labs Inc data using free add-ons & libraries
Get Shattuck Labs Inc Fundamental Data
Shattuck Labs Inc Fundamental data includes:
- Net Revenue: 1 000 K
- EBITDA: -53 834 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: -0.1432
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shattuck Labs Inc News
New
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
–First participants dosed in Phase 1 clinical trial of SL-325 in healthy volunteers – – Closed a private placement of up to $103 million in August 2025 to support advancement of SL-325 – –...
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
AUSTIN, TX and DURHAM, NC, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor n...
Regency Centers' Series A Preferred Stock Shares Cross 6.5% Yield Mark
In trading on Monday, shares of Regency Centers Corp's 6.250% Series A Cumulative Redeemable Preferred Stock (Symbol: REGCP) were yielding above the 6.5% mark based on its quarterly dividend (annualiz...
These stocks are moving in today's after hours session
As the regular session of the US market concludes on Thursday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] T...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
